Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants

<i>Background and Objectives</i>: Warfarin and a skeletal muscle relaxant are co-treatments in nearly a quarter-million annual United States (US) office visits. Despite international calls to minimize patient harm arising from anticoagulant drug interactions, scant data exist on clinical...

Full description

Bibliographic Details
Main Authors: Charles E. Leonard, Colleen M. Brensinger, Warren B. Bilker, Samantha E. Soprano, Neil Dhopeshwarkar, Todd E. H. Hecht, Scott E. Kasner, Edith A. Nutescu, Anne Holbrook, Matthew Carr, Darren M. Ashcroft, Cheng Chen, Sean Hennessy
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Medicina
Subjects:
central muscle relaxants
drug interactions
Medicaid
pharmacoepidemiology
thromboembolism
warfarin
Online Access:https://www.mdpi.com/1648-9144/58/9/1171

Internet

https://www.mdpi.com/1648-9144/58/9/1171

Similar Items